Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a condition called hyperinsulinemic hypoglycemia (where the body produces too much insulin, causing dangerously low blood sugar levels), confirmed through blood tests or specific medical tests.
- People for whom standard medications used to treat this condition (diazoxide or octreotide) have not worked.
- People (or their parents or legal guardians, if the person is a child) who have given written agreement to take part in the trial.
- People whose specialist doctor has decided that standard medical treatment is no longer a safe option and that surgery is needed to prevent serious low blood sugar episodes and protect brain health.
Who may not be able to join:
- People who have another serious illness or health condition that the trial doctors believe would make participation too risky.
- People for whom an MRI scan is not safe (though in some of these cases, a different type of scan called a PET/CT scan may be used instead — confirm with trial site).
- Children or individuals whose parents or guardians are not willing to consider surgery as a treatment option.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ana Maria Arbelaez, MD, MSCI, Washington University School of Medicine
Phone: 314-747-4659
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Increase Access to 18F-DOPA PET/MRI (or PET/CT) for patients with HI who failed medical therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.